Predicting response to HER2 kinase inhibition

Oncotarget. 2015 Jan 20;6(2):588-9. doi: 10.18632/oncotarget.3036.

Abstract

Comment on: Takagi S, Banno H, Hayashi A, Tamura T, Ishikawa T, Ohta Y. HER2 and HER3 cooperatively regulate cancer cell growth and determine sensitivity to the novel investigational EGFR/HER2 kinase inhibitor TAK-285. Oncoscience. 2014; 1:196-204.

Publication types

  • Comment
  • Editorial